Wellness Forever

Sector: Pharma & Healthcare (Pharmacy Retail Chain)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Wellness Forever operates in the pharma & healthcare segment of the Indian market, with a presence noted in the pharmacy retail chain category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Wellness Forever is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in pharmacy retail chain includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

April 2026

Wellness Forever continues to expand its retail footprint, opening 15 new stores across three Indian states in April 2026, mirroring a similar expansion pattern from August 2021 [2][5]. The company further solidified its presence in Nagpur in June 2022 with the inauguration of its first store by Nitin Gadkari [8]. Financially, the pharmacy retailer secured Rs 130 crore in funding from Poonawalla and Allana Group in November 2020 [9], subsequently filing for a Rs 1,600-crore IPO in September 2021 [7]. However, the company has faced operational challenges, notably responding to activist pressure in November 2025 by halting sales of glue traps following correspondence with authorities [1]. By mid-2024, Wellness Forever's hybrid pharmacy-grocery model faced disruption from the rapid rise of quick commerce competitors [4], while being recognised among India's top 30 healthtech startups by revenue in February 2026 [3].

Sources (8)

1. Mumbai: Wellness Forever Stops the Sale of Cruel Glue Traps After Activists Write to Authorities - The Times of India · The Times of India · Tue, 04 Nov 2025
2. Pharmacy Chain Wellness Forever Opens 15 New Stores across 3 Indian States - Indian Retailer · Indian Retailer · Wed, 08 Apr 2026
3. Top 30 Healthtech Startups In India 2026 By Revenue - Inc42 · Inc42 · Thu, 19 Feb 2026
4. Poonawalla-backed Wellness Forever was unrivalled as a half-pharmacy, half-grocer. Then came quick commerce - The Ken · The Ken · Mon, 29 Jul 2024
5. Wellness Forever opens 15 new stores across three states - Express Pharma · Express Pharma · Wed, 18 Aug 2021
6. Poonawalla-backed Wellness Forever to file for Rs 1,600-crore IPO - Moneycontrol.com · Moneycontrol.com · Tue, 14 Sep 2021
7. Nitin Gadkari inaugurates Wellness Forever’s first store in Nagpur - BioSpectrum India · BioSpectrum India · Mon, 27 Jun 2022
8. Wellness Forever raises Rs 130 crore from Poonawalla, Allana Group - Healthcare Radius · Healthcare Radius · Tue, 10 Nov 2020

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Wellness Forever occupies a position in the pharmacy retail chain category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on pharmacy retail chain benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the pharmacy retail chain value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Wellness Forever is a participant in the Indian pharmacy retail chain category, which forms part of the broader Pharma & Healthcare space. The Indian pharmacy retail chain market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Wellness Forever specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Wellness Forever mirrors the broader pharmacy retail chain category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Wellness Forever as a peer benchmark within the pharmacy retail chain category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Wellness Forever, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Wellness?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the pharma & healthcare (pharmacy retail chain) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Wellness and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 2 related project reports → Book a scoping call

Related KAMRIT project reports

These reports use Wellness Forever in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.